Results 111 to 120 of about 30,575 (221)

TRF2 Recovers Ischemic Postconditioning Cardioprotection in Aged Myocardiocytes by Regulating CSNK2A2 Localization and FUNDC1 Dephosphorylation

open access: yesAging Cell, Volume 25, Issue 8, August 2026.
Myocardial expression of telomeric repeat‐binding factor 2 (TRF2) was reduced in aged male mice and further downregulated following ischemic postconditioning (I/Post). Mechanistically, TRF2 confers cardioprotection by interacting with casein kinase 2 alpha 2 polypeptide (CSNK2A2) to modulate FUN14 domain‐containing protein 1 (FUNDC1) dephosphorylation,
Xuan Zhang   +5 more
wiley   +1 more source

Empowering Clinical Development With Disease Progression Modeling: Recommendations From the Clinical Trials Transformation Initiative

open access: yesClinical and Translational Science, Volume 19, Issue 8, August 2026.
ABSTRACT Evaluating the benefit–risk profile of a medical product requires comprehensive evidence that integrates information across development stages. Technological advances and broader use of real‐world data are enabling innovative quantitative paradigms characterized by greater efficiency, patient centricity, and sustainability.
Lindsay S. Kehoe   +7 more
wiley   +1 more source

Embolismo graso en un niño con distrofia muscular de duchenne y fractura bilateral de fémur. Una rara asociación.

open access: yesRevista de la Facultad de Medicina, 2007
Las fracturas de fémur en pacientes que sufren de distrofia muscular de Duchenne (DMD) son frecuentes, con una incidencia entre 15-44 por ciento. El embolismo graso se presenta en fracturas de huesos largos generalmente asociado a trauma de alta energía ...
Enrique Vergara Amador   +2 more
doaj  

Screening for brain‐related comorbidities in Duchenne muscular dystrophy: Construction, reliability, and validity of the BIND screener

open access: yesDevelopmental Medicine &Child Neurology, Volume 68, Issue 8, Page 1080-1096, August 2026.
The Brain Involvement iN Dystrophinopathies (BIND) screener is an 18‐item questionnaire with strong reliability and validity for identifying potential brain‐related comorbidities in Duchenne muscular dystrophy. It allows rapid, cross‐age and cross‐country screening for both clinical and research purposes, demonstrating good sensitivity and specificity.
Ruben Miranda   +46 more
wiley   +1 more source

Feasibility of an Adapted Participatory Group Programme for Caregivers of Children With Complex Neurodisability in the United Kingdom: Results From the Encompass‐2 Study

open access: yesHealth Expectations, Volume 29, Issue 4, August 2026.
ABSTRACT Introduction ‘Encompass’ is a participatory group‐based intervention originating from low‐ and middle‐income countries, co‐developed with parents and professionals to enhance the well‐being, health literacy and empowerment of caregivers of young children with complex neurodisability.
Kirsten Prest   +5 more
wiley   +1 more source

Bone health in adults with non‐ambulatory neuromuscular disorders: scoping review of risk factors, diagnosis and management

open access: yesInternal Medicine Journal, Volume 56, Issue 8, Page 1283-1300, August 2026.
Abstract Background Non‐ambulatory adults have an increased risk of osteoporosis and fractures due to reduced weight‐bearing and diminished neuromuscular stimulation, resulting in substantial morbidity and mortality. Aims This scoping review aimed to systematically evaluate risk factors, diagnostic indicators and management strategies for optimising ...
Thomas Bailey   +4 more
wiley   +1 more source

Prognostic Impact of Concomitant Genomic Alterations in FGFR2‐Positive Cholangiocarcinoma Treated With Pemigatinib

open access: yesLiver International, Volume 46, Issue 8, August 2026.
ABSTRACT Background & Aims Anti‐FGFR therapies changed the treatment landscape for patients with previously treated, advanced, or metastatic cholangiocarcinoma (CCA) harbouring FGFR2 fusions/rearrangements. However, primary resistance to FGFR inhibitors remains a key challenge. In the present real‐world study, we aimed to evaluate the prognostic impact
Carolina Liguori   +45 more
wiley   +1 more source

LKB1 Dysregulation in Duchenne Muscular Dystrophy Models: Disease Specificity and Epigenetic Control by HDAC Inhibitors

open access: yesAnnals of the New York Academy of Sciences, Volume 1562, Issue 1, August 2026.
Our study demonstrated that the LKB1–STRADα–MO25 complex was significantly downregulated in Duchenne muscular dystrophy (DMD) models, concurring with the disruption of mechano‐metabolic signaling. Treatment with the HDAC inhibitor, vorinostat, successfully restored LKB1 expression by suppressing specific repressor miRNAs.
Brigida Boccanegra   +17 more
wiley   +1 more source

Altered Skeletal Muscle Phosphate Metabolism After Muscle Damage Is Associated With Elevated Effort Perception During Exercise in Humans

open access: yesScandinavian Journal of Medicine &Science in Sports, Volume 36, Issue 8, August 2026.
ABSTRACT It remains unclear why exercising damaged muscles is perceived as disproportionately more effortful. Given the known role of inorganic phosphate (Pi) in fatigue and afferent sensory signaling, we tested whether muscle damage disrupts phosphate metabolism and whether this is associated with heightened ratings of perceived exertion (RPE ...
Jamie Stewart McPhee   +5 more
wiley   +1 more source

Cardiac MRI in cardiac dystrophinopathy: recommendations on imaging. [PDF]

open access: yesOpen Heart
McDiarmid A   +15 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy